Pay in 4 interest-free payments of $6.08 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
The FDA must go through formal rulemaking to update the 503A Bulks List, which involves issuing a proposed rule for public comment before that rule is finalized
The low price point of research chemical GHK-Cu is not an advantage when the risks include systemic infection, immune reactions, and unknown contamination
Active tumor-therapeutic liposomal bacteriobot combining a drug (paclitaxel)-encapsulated liposome with targeting bacteria (Salmonella Typhimurium)
Better stability management
US$ 27.91
US$ 20.35
US$ 22.41
US$ 28.61
US$ 24.40
US$ 22.36
US$ 27.89
US$ 26.24
